Table 2.
(A) Predictors of fibrosis progression | Hazard Ratio (95% CI) | P-value |
T2DM, unadjusted | 1.45 (1.04 – 2.03) | 0.03 |
T2DM, adjusted for age and sex | 1.42 (1.00 – 2.00) | 0.05 |
T2DM, adjusted for age, sex, BMI, and Hispanic race/ethnicity | 1.52 (1.07 – 2.17) | 0.02 |
T2DM, adjusted for age, sex, BMI, Hispanic race/ethnicity, and baseline fibrosis stage | 1.69 (1.17 – 2.43) | 0.005 |
(B) Predictors of fibrosis regression | Hazard Ratio (95% CI) | P-value |
T2DM, unadjusted | 1.15 (0.77 – 1.71) | 0.49 |
T2DM, adjusted for age and sex | 1.36 (0.90 – 2.07) | 0.15 |
T2DM, adjusted for age, sex, BMI, and Hispanic race/ethnicity | 1.38 (0.90 – 2.11) | 0.14 |
T2DM, adjusted for age, sex, BMI, Hispanic race/ethnicity, and baseline fibrosis stage | 1.29 (0.84 – 1.99) | 0.24 |
Abbreviation: T2DM, type 2 diabetes mellitus; BMI, body mass index